184 related articles for article (PubMed ID: 37881138)
21. Leukotriene receptor antagonists in addition to usual care for acute asthma in adults and children.
Watts K; Chavasse RJ
Cochrane Database Syst Rev; 2012 May; 2012(5):CD006100. PubMed ID: 22592708
[TBL] [Abstract][Full Text] [Related]
22. Prognosis of adults and children following a first unprovoked seizure.
Neligan A; Adan G; Nevitt SJ; Pullen A; Sander JW; Bonnett L; Marson AG
Cochrane Database Syst Rev; 2023 Jan; 1(1):CD013847. PubMed ID: 36688481
[TBL] [Abstract][Full Text] [Related]
23. Correlations of health-related quality of life questionnaire results in asthma and allergic rhinitis: effects of a leukotriene receptor antagonist.
Ichimaru Y; Kanazawa H; Kamoi H; Kyoh S; Tochino Y; Kodama T; Hirata K
J Int Med Res; 2008; 36(3):559-66. PubMed ID: 18534139
[TBL] [Abstract][Full Text] [Related]
24. Cysteinyl-leukotriene receptor antagonists: present situation and future opportunities.
Capra V; Ambrosio M; Riccioni G; Rovati GE
Curr Med Chem; 2006; 13(26):3213-26. PubMed ID: 17168708
[TBL] [Abstract][Full Text] [Related]
25. Leukotriene receptor antagonists for eczema.
Ferguson L; Futamura M; Vakirlis E; Kojima R; Sasaki H; Roberts A; Mori R
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD011224. PubMed ID: 30343498
[TBL] [Abstract][Full Text] [Related]
26. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
; ;
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
[TBL] [Abstract][Full Text] [Related]
27. Risk of Neuropsychiatric Diseases According to the Use of a Leukotriene Receptor Antagonist in Middle-Aged and Older Adults with Asthma: A Nationwide Population-Based Study Using Health Claims Data in Korea.
Shim JS; Kim MH; Kim MH; Cho YJ; Chun EM
J Allergy Clin Immunol Pract; 2021 Dec; 9(12):4290-4297. PubMed ID: 34166842
[TBL] [Abstract][Full Text] [Related]
28. Asthma pharmacotherapy: an update on leukotriene treatments.
Trinh HKT; Lee SH; Cao TBT; Park HS
Expert Rev Respir Med; 2019 Dec; 13(12):1169-1178. PubMed ID: 31544544
[No Abstract] [Full Text] [Related]
29. Leukotriene receptor antagonists as maintenance and intermittent therapy for episodic viral wheeze in children.
Brodlie M; Gupta A; Rodriguez-Martinez CE; Castro-Rodriguez JA; Ducharme FM; McKean MC
Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD008202. PubMed ID: 26482324
[TBL] [Abstract][Full Text] [Related]
30. Safety of leukotriene receptor antagonists in pregnancy.
Bakhireva LN; Jones KL; Schatz M; Klonoff-Cohen HS; Johnson D; Slymen DJ; Chambers CD;
J Allergy Clin Immunol; 2007 Mar; 119(3):618-25. PubMed ID: 17336611
[TBL] [Abstract][Full Text] [Related]
31. A review of montelukast in the treatment of asthma and allergic rhinitis.
Nayak A
Expert Opin Pharmacother; 2004 Mar; 5(3):679-86. PubMed ID: 15013935
[TBL] [Abstract][Full Text] [Related]
32. Clinical practice guideline: Allergic rhinitis.
Seidman MD; Gurgel RK; Lin SY; Schwartz SR; Baroody FM; Bonner JR; Dawson DE; Dykewicz MS; Hackell JM; Han JK; Ishman SL; Krouse HJ; Malekzadeh S; Mims JW; Omole FS; Reddy WD; Wallace DV; Walsh SA; Warren BE; Wilson MN; Nnacheta LC;
Otolaryngol Head Neck Surg; 2015 Feb; 152(1 Suppl):S1-43. PubMed ID: 25644617
[TBL] [Abstract][Full Text] [Related]
33. Seizures as a rare but serious adverse effect of leukotriene receptor.
Erdem SB; Karaman S; Nacaroglu HT; Unsal Karkıner CS; Yazıcı S; Can D
Ann Allergy Asthma Immunol; 2016 Jul; 117(1):99-101. PubMed ID: 27211058
[No Abstract] [Full Text] [Related]
34. Clinical evaluation of leukotriene receptor antagonists in preventing common cold-like symptoms in bronchial asthma patients.
Horiguchi T; Ohira D; Kobayashi K; Hirose M; Miyazaki J; Kondo R; Tachikawa S
Allergol Int; 2007 Sep; 56(3):263-7. PubMed ID: 17582209
[TBL] [Abstract][Full Text] [Related]
35. Role for cysteinyl leukotriene receptor antagonist therapy in asthma and their potential role in allergic rhinitis based on the concept of "one linked airway disease".
Meltzer EO
Ann Allergy Asthma Immunol; 2000 Feb; 84(2):176-85; quiz 185-7. PubMed ID: 10719774
[TBL] [Abstract][Full Text] [Related]
36. Comparative outcomes of leukotriene receptor antagonists and long-acting β-agonists as add-on therapy in asthmatic patients: a population-based study.
Sadatsafavi M; Lynd L; Marra C; Bedouch P; Fitzgerald M
J Allergy Clin Immunol; 2013 Jul; 132(1):63-9. PubMed ID: 23545274
[TBL] [Abstract][Full Text] [Related]
37. Influence of weight status in the response to Step-2 maintenance therapies in children with asthma.
Longo C; Bartlett G; Schuster T; Ducharme FM; MacGibbon B; Barnett TA
BMJ Open Respir Res; 2019; 6(1):e000401. PubMed ID: 31179003
[TBL] [Abstract][Full Text] [Related]
38. Cost effectiveness of leukotriene receptor antagonists versus inhaled corticosteroids for initial asthma controller therapy: a pragmatic trial.
Wilson EC; Sims EJ; Musgrave SD; Shepstone L; Blyth A; Murdoch J; Mugford HM; Juniper EF; Ayres JG; Wolfe S; Freeman D; Gilbert RF; Harvey I; Hillyer EV; Price D
Pharmacoeconomics; 2010; 28(7):585-95. PubMed ID: 20550224
[TBL] [Abstract][Full Text] [Related]
39. Leukotriene receptor antagonists: clinical potential in allergic rhinitis.
Diamant Z; Fokkens WJ
Rhinology; 2001 Dec; 39(4):187-90. PubMed ID: 11826686
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
